NXL Stock Price, Nexalin Technology Inc Quote, Chart

Market Summary

USD1.42+0.04

Market Closed

2.90%

NXL Stock Price

View Fullscreen

NXL RSI Chart

NXL Valuation

Market Cap

10.6M

Price/Earnings (Trailing)

-2.27

Price/Sales (Trailing)

95.35

Price/Free Cashflow

-2.75

NXL Price/Sales (Trailing)

NXL Profitability

Operating Margin

76.81%

Return on Equity

-144.97%

Return on Assets

-128%

Free Cashflow Yield

-36.32%

NXL Fundamentals

NXL Revenue

Revenue (TTM)

110.7K

Rev. Growth (Yr)

-84.79%

Rev. Growth (Qtr)

133.38%

NXL Earnings

Earnings (TTM)

-4.6M

Earnings Growth (Yr)

-6.99%

Earnings Growth (Qtr)

66.02%

Breaking Down NXL Revenue

Last 7 days

-0.7%

Last 30 days

82.1%

Last 90 days

305.7%

Trailing 12 Months

71.1%

How does NXL drawdown profile look like?

NXL Financial Health

Current Ratio

8.07

NXL Investor Care

Shares Dilution (1Y)

2.06%

Diluted EPS (TTM)

-0.63

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	1.0M	716.1K	413.4K	110.7K
2022	438.4K	732.7K	1.0M	1.3M
2021	0	0	0	144.1K

Get all data in R, Python etc through our Historical Stock Data APIs

Which funds bought or sold NXL recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Feb 14, 2024	CITADEL ADVISORS LLC	added	4.00	-264	126	-%
Feb 14, 2024	CITADEL ADVISORS LLC	sold off	-100	-6,668	-	-%
Feb 14, 2024	SUSQUEHANNA INTERNATIONAL GROUP, LLP	sold off	-100	-8,075	-	-%
Feb 14, 2024	BOOTHBAY FUND MANAGEMENT, LLC	unchanged	-	-474	5,465	-%
Feb 14, 2024	CLEAR STREET LLC	added	0.11	-1,000	1,000	-%
Feb 14, 2024	Altium Capital Management LP	unchanged	-	-1,701	924	-%
Feb 13, 2024	GEODE CAPITAL MANAGEMENT, LLC	unchanged	-	-2,577	14,644	-%
Feb 13, 2024	Tower Research Capital LLC (TRC)	added	0.06	-315	3,674	-%
Feb 13, 2024	ARMISTICE CAPITAL, LLC	unchanged	-	-5,265	2,860	-%
Feb 09, 2024	UBS Group AG	new	-	1.00	1.00	-%

Are Funds Buying or Selling NXL?

Are funds buying NXL calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own NXL

No. of Funds

Recent SEC filings of Nexalin Technology Inc

View All Filings

Date Filed	Form Type	Document
Apr 26, 2024	8-K	Current Report
Apr 16, 2024	S-3	S-3
Apr 11, 2024	8-K	Current Report
Mar 27, 2024	10-K	Annual Report
Mar 20, 2024	8-K	Current Report

Peers (Alternatives to Nexalin Technology Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
ABT	186.5B	40.1B	-5.27%	-1.83%	32.59	4.65	-8.12%	-17.45%
BDX	66.9B	19.5B	-6.10%	-12.08%	53.25	3.43	4.02%	-22.04%
ALGN	23.2B	3.9B	-5.77%	-2.75%	52.14	6.01	3.42%	23.09%
BAX	20.4B	14.8B	-6.00%	-14.25%	7.67	1.38	2.12%	209.17%
MID-CAP
ATR	9.5B	3.5B	-0.91%	22.96%	30.27	2.67	6.16%	35.06%
HSIC	9.4B	12.3B	-2.70%	-9.94%	22.59	0.76	-2.44%	-22.68%
BIO	8.1B	2.7B	-21.14%	-36.84%	-12.64	3.01	-4.68%	82.43%
XRAY	6.3B	4.0B	-8.20%	-26.06%	-47.15	1.6	1.10%	85.84%
AXNX	3.4B	366.4M	-3.27%	17.57%	-560.12	9.28	33.86%	89.83%
PDCO	2.3B	6.6B	-7.27%	-4.94%	11.93	0.35	2.78%	-0.87%
SMALL-CAP
AHCO	1.3B	3.2B	-12.41%	-15.32%	-1.95	0.41	7.73%	-1066.14%
ANIK	379.4M	166.7M	0.04%	-0.97%	-4.59	2.28	6.67%	-456.34%
ANGO	232.3M	324.0M	1.75%	-30.04%	-1.21	0.72	-3.19%	-337.41%
APYX	49.9M	52.3M	2.13%	-52.32%	-2.67	0.95	17.61%	19.28%
AEMD	3.6M	3.7M	-20.47%	240.00%	-0.29	0.95	5.77%	8.23%

Nexalin Technology Inc News

Latest updates

Nexalin Technology Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)										(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3
Revenue	-100.0%	-	83.00	36.00	37.00	38.00	545	414	323	190	56.00
Cost Of Revenue	31.7%	5.00	4.00	9.00	7.00	7.00	187	123	46.00	-	9.00
Gross Profit	-24.0%	15.00	20.00	26.00	23.00	32.00	358	291	277	-	47.00
Operating Expenses	-32.7%	1,640	2,436	903	803	751	651	736	652	-	1,842
S&GA Expenses	-46.1%	1,049	1,945	480	345	408	479	386	218	-	1,622
Interest Expenses	1032.1%	50.00	-5.33	-5.52	9.00	87.00	-10.45	-17.30	18.00	-	27.00
Net Income	66.0%	-780	-2,297	-822	-748	-729	-135	-439	-393	-595	-1,799
Net Income Margin	-277.4%	-41.98*	-11.12*	-3.40*	-2.02*	-1.28*	-1.52*	-4.41*	-11.15*	-42.19*	-
Free Cashflow	-43.2%	-1,004	-701	-815	-1,314	-906	-943	-162	-203	-	-

Balance Sheet

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Balance Sheet							(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2021Q4
Assets	-18.1%	3,632	4,434	5,176	5,930	7,432	8,353	754
Current Assets	-19.5%	3,430	4,263	5,112	5,876	7,425	8,345	753
Cash Equivalents	60.6%	580	361	232	175	163	7,864	662
Inventory	-1.4%	156	159	160	158	154	152	31.00
Net PPE	-100.0%	-	100*	234*	368*	503*	636*	1.00
Liabilities	-64.5%	425	1,197	1,183	1,195	1,953	1,998	2,436
Current Liabilities	-64.5%	425	1,197	1,183	1,195	1,949	1,980	2,364
Shareholder's Equity	-0.9%	3,207	3,237	3,993	4,735	5,479	6,355	-1,681
Retained Earnings	-1.0%	-77,038	-76,257	-73,960	-73,137	-72,389	-71,659	-70,691
Additional Paid-In Capital	0.9%	80,238	79,486	77,913	77,824	77,824	78,007	69,005
Accumulated Depreciation	3.9%	3.00	3.00	2.00	2.00	2.00	30.00	30.00
Shares Outstanding	0%	7,437	7,437	7,287	7,287	7,287	4,995	4,880
Float	-	-	-	4,994	-	-	23,477	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)										(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3
Cashflow From Operations	-43.2%	-1,004	-701	-815	-1,314	-906	-943	-162	-203	-	-
Share Based Compensation	-52.2%	752	1,573	-	-	-182	184	172	98.00	-	-
Cashflow From Investing	47.2%	1,223	831	872	1,527	-	-	-	-	-	-
Cashflow From Financing	-	-	-	-	-200	-	8,516	-5.00	100*	-	-

NXL Income Statement

2023-12-31

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Income Statement [Abstract]
Revenues, net (Includes related party of $3,614 and $1,183,367 for the year ended December 31, 2023 and December 31, 2022, respectively)	$ 110,748	$ 1,321,357
Cost of revenues	25,688	363,212
Gross profit	85,060	958,145
Operating expenses:
Professional fees	574,598	605,329
Salaries and benefits	1,387,916	694,108
Selling, general and administrative	3,818,842	1,491,739
Total operating expenses	5,781,356	2,791,176
Loss from operations	(5,696,296)	(1,833,031)
Other income (expense), net:
Interest income (expense), net	(38,835)	(59,382)
Gain on sale of short-term investments	231,880
Other income	239,542	171,681
Gain on extinguishment of debt	615,000
Other income - PPP loan forgiveness		22,916
Total other income (expense), net	1,047,587	135,215
Net loss	(4,648,709)	(1,697,816)
Other comprehensive income (loss):
Unrealized gain (loss) from short-term investments	(36,718)	36,313
Comprehensive loss	$ (4,685,427)	$ (1,661,503)
Net loss per share attributable to common stockholders - Basic	$ (0.63)	$ (0.30)
Net loss per share attributable to common stockholders - Diluted	$ (0.63)	$ (0.30)
Weighted Average Shares Outstanding - Basic	7,357,029	5,572,402
Weighted Average Shares Outstanding - Diluted	7,357,029	5,572,402

NXL Balance Sheet

2023-12-31

CONSOLIDATED BALANCE SHEETS - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Current Assets:
Cash and cash equivalents	$ 580,230	$ 162,743
Short-term investments	2,368,203	6,831,192
Accounts receivable (Includes related party of $3,614 and $0, respectively)	9,369	4,875
Inventory	156,420	154,370
Prepaid expenses and other current assets	315,670	272,282
Total Current Assets	3,429,892	7,425,462
ROU Asset	496	6,171
Equipment, net of accumulated depreciation of $2,684 and $2,181, respectively		503
Intangible assets, net	105,528
Equity Method Investment	96,000
Total Assets	3,631,916	7,432,136
Current Liabilities:
Accounts payable (Includes related party of $0 and $260,000, respectively)	159,534	658,367
Accrued expenses	261,284	539,822
Lease liability, current portion	4,463	50,797
Loan payable - officer		200,000
Note payable		500,000
Total Current Liabilities	425,281	1,948,986
Long-term Liabilities:
Lease liability, net of current portion		4,463
Total Liabilities	425,281	1,953,449
Stockholders’ Equity:
Common stock, $0.001 par value; 100,000,000 shares authorized; 7,436,562 and 7,286,562 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively	7,437	7,287
Accumulated other comprehensive income (loss)	(405)	36,313
Additional paid in capital	80,237,652	77,824,427
Accumulated deficit	(77,038,049)	(72,389,340)
Total Stockholders’ Equity	3,206,635	5,478,687
Total Liabilities and Stockholders’ Equity	$ 3,631,916	$ 7,432,136

About Nexalin Technology Inc

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. It licenses and markets Nexalin Device, a non-invasive and drug-free therapy for the treatment of anxiety and insomnia. The company's Nexalin device emits a patented frequency-based waveform, which stimulates a positive response from the mid-brain structures associated with various mental health disorders. In addition, it designs and develops Generation 2 and Generation 3, a medical device that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, Alzheimer's disease, and dementia. The company is based in Houston, Texas.

CEO	Mr. Mark White
WEBSITE	nexalin.com
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	6

Nexalin Technology Inc Frequently Asked Questions

What is the ticker symbol for Nexalin Technology Inc? What does NXL stand for in stocks?

NXL is the stock ticker symbol of Nexalin Technology Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Nexalin Technology Inc (NXL)?

As of Fri Apr 26 2024, market cap of Nexalin Technology Inc is 10.56 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of NXL stock?

You can check NXL's fair value in chart for subscribers.

What is the fair value of NXL stock?

You can check NXL's fair value in chart for subscribers. The fair value of Nexalin Technology Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Nexalin Technology Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for NXL so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Nexalin Technology Inc a good stock to buy?

The fair value guage provides a quick view whether NXL is over valued or under valued. Whether Nexalin Technology Inc is cheap or expensive depends on the assumptions which impact Nexalin Technology Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for NXL.

What is Nexalin Technology Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Apr 26 2024, NXL's PE ratio (Price to Earnings) is -2.27 and Price to Sales (PS) ratio is 95.35. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. NXL PE ratio will change depending on the future growth rate expectations of investors.